Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Abbott discloses antibacterial tiacumicin derivatives

Jan. 16, 1997

New antibiotics from BTG

Jan. 16, 1997

3DP and ViroPharma establish drug discovery collaboration

Jan. 15, 1997

Xoma expands pivotal Neuprex trials

Jan. 15, 1997

Antifungal agent described by Roussel Morishita

Jan. 15, 1997

FDA to review AmBisome NDA

Jan. 14, 1997

More oxazolidinone antimicrobial agents under study at P&U

Jan. 14, 1997

Merck & Co. discloses novel antifungal agents

Jan. 14, 1997

The Liposome Company's Abelcet receives marketing approval in 14th country

Jan. 13, 1997

Sequus' Amphotec earns 19th marketing approval

Jan. 10, 1997

Popular Stories

Today's news in brief
BioWorld
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...